CBD vs THC: molecules, receptors and how THC is removed

CBD and THC at a glance

This table describes the molecules, not the legal status or quality of every finished product bearing their names.

Same formula, different molecular architecture

CBD and Δ9-THC both contain 21 carbon atoms, 30 hydrogens and two oxygens. They are structural isomers: the same inventory of atoms is connected in a different pattern. THC contains a closed oxygen-bearing ring; CBD has a more flexible open arrangement with two hydroxyl groups. That apparently small architectural change alters three-dimensional shape, flexibility and receptor interaction.

Why THC intoxicates and CBD does not behave the same way

The endocannabinoid system includes cannabinoid receptors, naturally produced signalling molecules such as anandamide and 2-arachidonoylglycerol (2-AG), and enzymes that make or break down those signals. CB1 receptors are abundant in parts of the brain involved in memory, movement, appetite and perception; CB2 receptors are found largely in immune and peripheral tissues, although this division is not absolute.

Δ9-THC is a partial agonist at cannabinoid CB1 and CB2 receptors. CB1 signalling in the central nervous system is central to THC’s characteristic intoxicating effects. CBD does not activate these receptors in the same straightforward way: reviews describe low binding affinity at CB1 and CB2, possible negative allosteric modulation of CB1, and activity across other molecular targets including TRP channels and 5-HT1A signalling. Much of the mechanistic evidence comes from laboratory models, and an interaction observed in vitro does not automatically predict a meaningful effect in people.

It is therefore clearer to describe consumer CBD as not intoxicating in the THC-like sense, rather than biologically inactive or universally “non-psychoactive”. CBD can still interact with the body, cause adverse effects and interact with medicines. This page explains chemistry; it does not claim a consumer supplement treats a condition.

The plant initially makes acidic cannabinoids

Fresh cannabis material contains much of its cannabinoid content as carboxylic acids, including CBDA and THCA. Enzymes branch from a common precursor, CBGA. Genetics largely determine whether a plant directs more precursor towards CBDA or THCA, while growing conditions, harvest timing and storage affect the final profile.

Heat, storage and processing can remove a carboxyl group as carbon dioxide—a reaction called decarboxylation—producing neutral CBD or THC. Extraction temperature and processing history therefore affect what a laboratory measures. Laboratories often report acidic and neutral forms separately; a “total THC” calculation commonly adjusts THCA for the molecular mass lost during decarboxylation.

How a hemp extract becomes a CBD ingredient

There is no single universal factory recipe. The FSA’s published novel-food material describes a representative multi-step route: drying, primary solvent extraction, decarboxylation, winterisation, distillation, isolation, crystallisation, filtering, washing, drying and final dilution in oil. A broad- or full-spectrum ingredient may stop at a different point and preserve a wider mixture.

Supercritical CO₂ uses carbon dioxide above its critical temperature and pressure as a tunable solvent. Ethanol extraction uses food- or pharmaceutical-grade alcohol and can operate warm or cold. Neither method is intrinsically proof of a superior finished product: selectivity, solvent recovery, process controls and final testing matter more than a marketing headline.

How THC is reduced or removed

Primary extraction is not selective enough to guarantee pure CBD. Cannabinoids share lipid solubility and related chemistry, so an extract can carry CBD, THC and other cannabinoids together. The UK Home Office notes that isolating CBD without traces of controlled cannabinoids is extremely difficult.

Chromatography separates compounds because they travel differently through a stationary material under a moving solvent. The THC-rich portion can be diverted from the CBD-rich portion. Vacuum distillation separates fractions using volatility at reduced pressure and may be used before or alongside chromatography. Crystallisation can purify CBD isolate because CBD forms a crystalline solid under controlled conditions while many other components remain in solution.

Each method has trade-offs: yield, cost, solvent use, heat exposure and how much of the original terpene/cannabinoid mixture remains. A responsible manufacturer validates its own process and tests every relevant batch; a generic diagram cannot certify a particular bottle.

What “THC-free” really needs to show

A laboratory does not demonstrate metaphysical zero. It reports whether an analyte was found above a method’s limit of detection or limit of quantification. “ND” usually means not detected at that method’s stated sensitivity. It does not mean no molecule could exist in the sample.

Cannabinoid laboratories commonly use liquid chromatography because it can measure acidic and neutral cannabinoids without intentionally heating them first. Gas chromatography heats the sample during analysis, which can decarboxylate acidic cannabinoids unless the method accounts for that conversion. The method, calibration, sample preparation and uncertainty all affect what a result can support.

1. Match the certificate’s product and batch number to the container.
2. Check Δ9-THC, THCA and any other controlled cannabinoids included in the panel.
3. Read the units carefully: mg/g, mg/ml, percentage and total mg are not interchangeable.
4. Find the LOD/LOQ or reporting limit. “ND” without method sensitivity is incomplete.
5. Check the laboratory identity, date and accreditation scope where stated.
6. Separate cannabinoid potency from contaminant panels such as solvents, pesticides, metals and microbes.

Use our CBD lab-report reader for a structured check.

Safety, medicines and drug testing

UK legal context

Pure CBD is not controlled under the Misuse of Drugs Act 1971, but THC, cannabinol and several related cannabinoids are controlled Class B drugs. A CBD product containing controlled substances can itself be controlled unless the relevant legal conditions are met. The Home Office’s exempt-product definition includes several cumulative requirements; the often-repeated “1mg” point is not a general permission to add THC and is not a simple product-quality threshold. Businesses need current legal and analytical advice.

For ingestible CBD, novel-food authorisation is a separate regulatory question. In Great Britain, products must follow the applicable novel-food route, while controlled-drug analysis, general food law, labelling and any medicines claims remain separate checks. Passing one does not prove compliance with every other regime. Northern Ireland may operate under different food-law arrangements, so UK-wide sellers must check the market in which a product is supplied.

Glossary

Cannabinoid

A class of compounds that includes plant cannabinoids such as CBD and THC, and endogenous cannabinoids made by the body.

Decarboxylation

Loss of a carboxyl group as CO₂, converting CBDA or THCA into CBD or THC.

LOD / LOQ

The limit of detection and limit of quantification for an analytical method.

Isomer

A molecule with the same chemical formula as another but a different arrangement of atoms.

Phytocannabinoid

A cannabinoid produced by a plant.

Certificate of analysis

A laboratory report for a specified sample or batch; its scope depends on the tests performed.